About Raptor Pharma
Raptor Pharma is a company based in Novato (United States) founded in 2005 was acquired by Horizon Therapeutics in September 2016.. The company has 128 employees as of December 31, 2016. Raptor Pharma has completed 1 acquisition, including TorreyPines Therapeutics. Raptor Pharma offers products and services including Biologic Medicines, DNA Encoded Libraries, ATOMIC Model, and Omics Research. Raptor Pharma operates in a competitive market with competitors including Insitro, BridgeBio, ATAI, Forge Biologics and Spark Therapeutics, among others.
- Headquarter Novato, United States
- Employees 128 as on 31 Dec, 2016
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Raptor Pharmaceuticals Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$75 M (USD), Post-IPO
Sep 01, 2015
-
Investors
Horizon Therapeutics
& 1 more
-
Employee Count
128
as on Dec 31, 2016
- Investments & Acquisitions
-
Acquired by
Horizon Therapeutics
(Sep 12, 2016)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Raptor Pharma
Raptor Pharma offers a comprehensive portfolio of products and services, including Biologic Medicines, DNA Encoded Libraries, ATOMIC Model, and Omics Research. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Treatments for serious diseases using biologic methods
Platform for screening compounds to develop new therapies
Machine learning system to accelerate clinical trials
Approach for gaining insights into disease biology
Funding Insights of Raptor Pharma
- Total Funding Total Funding
- Total Rounds 8
- Last Round Post-IPO — $75.0M
-
First Round
First Round
(30 Jun 2008)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2015 | Amount | Post-IPO - Raptor Pharma | Valuation |
investors |
|
| Jul, 2014 | Amount | Post-IPO - Raptor Pharma | Valuation |
investors |
|
| Dec, 2012 | Amount | Debt – Conventional - Raptor Pharma | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Raptor Pharma
Raptor Pharma has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Horizon Therapeutics and HealthCare Royalty Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare royalty investments are focused on US and UK markets.
|
Founded Year | Domain | Location | |
|
Developer of drugs for treating rare and autoimmune diseases
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Raptor Pharma
Raptor Pharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include TorreyPines Therapeutics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Small molecule drugs for CNS disorders are developed.
|
2000 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Raptor Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Raptor Pharma Comparisons
Competitors of Raptor Pharma
Raptor Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insitro, BridgeBio, ATAI, Forge Biologics and Spark Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| domain | founded_year | HQ Location |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| domain | founded_year | HQ Location |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases are developed to treat patients.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| domain | founded_year | HQ Location |
Provider of cell therapies to treat cancer and hematologic conditions
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Raptor Pharma
When was Raptor Pharma founded?
Raptor Pharma was founded in 2005 and raised its 1st funding round 3 years after it was founded.
Where is Raptor Pharma located?
Raptor Pharma is headquartered in Novato, United States. It is registered at Novato, California, United States.
How many employees does Raptor Pharma have?
As of Dec 31, 2016, the latest employee count at Raptor Pharma is 128.
What does Raptor Pharma do?
Raptor Pharma was founded in 2005 and is based in Novato, United States. Focus is placed on the development of small molecule therapeutics targeting rare diseases within the pharmaceutical sector. Two products have been commercialized: PROCYSBI delayed-release capsules for nephropathic cystinosis management and QUINSAIR for chronic pulmonary infections due to Pseudomonas aeruginosa in cystic fibrosis patients. Active clinical programs are maintained in Huntingtons disease, Leigh syndrome, and other mitochondrial disorders.
Who are the top competitors of Raptor Pharma?
Raptor Pharma's top competitors include Spark Therapeutics, BridgeBio and Forge Biologics.
What products or services does Raptor Pharma offer?
Raptor Pharma offers Biologic Medicines, DNA Encoded Libraries, ATOMIC Model, and Omics Research.
How many acquisitions has Raptor Pharma made?
Raptor Pharma has made 1 acquisition, including TorreyPines Therapeutics.
Who are Raptor Pharma's investors?
Raptor Pharma has 2 investors. Key investors include Horizon Therapeutics, and HealthCare Royalty Partners.